Imagen de Portada
Código QR

Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection: meta-analyses of the randomised evidence.

Publicado en:Lancet Vol. 353; no. 9169; pp. 2014 - 2026
Formato: research tables/charts Journal Article
Publicado: Lancet 6/12/1999
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=107212575&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 107212575
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01406736
        LAN
      jtl: Lancet
      issn: 01406736
      maglogo: N
    pubinfo:
      dt: 6/12/1999
      vid: 353
      iid: 9169
      pid: 1297
      pub: Lancet
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        107212575
        107212575
        1999061920
        10.1016/s0140-6736(98)12263-8
        NLM10376616
        107212575
      ppf: 2014
      ppct: 12
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection: meta-analyses of the randomised evidence.
      aug:
      sug:
        subj:
          Anti-HIV Agents
          Antiviral Agents Therapeutic Use
          Funding Source
          Meta Analysis
          Disease Progression
          Survival
          HIV Infections Mortality
          Human
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N